Relating ciliary dysfunction to clinical phenotypes in COPD
J. Tonkin (London, United Kingdom), A. Rogers (London, United Kingdom), C. Orton (London, United Kingdom), F. Conway (London, United Kingdom), B. Vijayakumar (London, United Kingdom), L. Chan (London, United Kingdom), A. Tana (London, United Kingdom), C. Caneja (London, United Kingdom), L. Avanzi (London, United Kingdom), R. Wawman (London, United Kingdom), A. Baikov (London, United Kingdom), P. Bhavsar (London, United Kingdom), P. Shah (London, United Kingdom)
Source: International Congress 2022 – Advanced models for drug discovery and functional changes in lung disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Tonkin (London, United Kingdom), A. Rogers (London, United Kingdom), C. Orton (London, United Kingdom), F. Conway (London, United Kingdom), B. Vijayakumar (London, United Kingdom), L. Chan (London, United Kingdom), A. Tana (London, United Kingdom), C. Caneja (London, United Kingdom), L. Avanzi (London, United Kingdom), R. Wawman (London, United Kingdom), A. Baikov (London, United Kingdom), P. Bhavsar (London, United Kingdom), P. Shah (London, United Kingdom). Relating ciliary dysfunction to clinical phenotypes in COPD. 2066
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|